Zhe Tang
Tongji University(CN)Beijing Institute of Technology(CN)Central South University(CN)Guangxi Medical University(CN)Sichuan University(CN)Kunming Medical University(CN)Zhengzhou University(CN)Rajamangala University of Technology Rattanakosin(TH)Shanghai University of Traditional Chinese Medicine(CN)Henan Institute of Technology(CN)Ordnance Engineering College(CN)Yan'an Hospital Affiliated To Kunming Medical University(CN)Second Affiliated Hospital of Zhejiang University(CN)Zhejiang University(CN)South China University of Technology(CN)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Lung Cancer Treatments and Mutations, PARP inhibition in cancer therapy, Sexual function and dysfunction studies, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer(2019)230 cited
- → Dual MET–EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer(2008)182 cited
- → ATR Inhibition Induces CDK1–SPOP Signaling and Enhances Anti–PD-L1 Cytotoxicity in Prostate Cancer(2021)139 cited
- → Long non-coding RNA GAS5 antagonizes the chemoresistance of pancreatic cancer cells through down-regulation of miR-181c-5p(2017)101 cited
- → Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer(2020)80 cited
- → MET-Independent Lung Cancer Cells Evading EGFR Kinase Inhibitors Are Therapeutically Susceptible to BH3 Mimetic Agents(2011)79 cited